VALDEZ CRUZ, NORMA ADRIANA
CIENCIAS DE LA VIDA · Nivel 2
en Universidad Nacional Autónoma de México
Dr. Norma Adriana Valdez-Cruz is a researcher and group leader of the Department of Bionanotechnology of the Center for Nanosciences...
Dr. Norma Adriana Valdez-Cruz is a researcher and group leader of the Department of Bionanotechnology of the Center for Nanosciences and Nanotechnology (CNyN) at the Universidad Nacional Autónoma de México (UNAM). The Doctor is Q.F.B, by the Universidad Autónoma de Baja California, an entity that was given an honorary mention. She completed her doctorate at UNAM (2004) under the mentorship of Dr. Lourival Possani, obtaining the Alfonso Caso Medal. She carried out postdoctoral internships at the CIB in Colombia, at the University of Sussex, England, with a scholarship from the “Wellcome Trust”, and at the company Probiomed, S.A. de C.V. She has been an Academic Leader since 2010, starting at the Institute of Biomedical Research and currently at the CNyN, where she is a “B” Full Researcher. She was honored with the National University Recognition Distinction for Young Academics at UNAM, in 2013. In 2025, she was awarded by UNAM with the Sor Juana Inés de la Cruz Recognition. Since 2016, she has been Associate Editor at “Microbial Cell Factories” journal and participated until 2019 as an invited Expert of the COFEPRIS New Molecules Committee and level 2 at the National Research System.
Dr. Valdez's investigations resulted in 72 publications that included 58 indicated articles. Its publications have received more than 1555 citations in Scopus and more than 2500 in Scholar Google. She is the author of seven book chapters, has two patents granted in Mexico, one registered in the USA, and a patent application. She has eight disclosure publications and 53 concessions in GenBank. His line of research includes “Biochemical and molecular studies on the regulation of the synthesis of therapeutic recombinant proteins, produced in prokaryotic or eukaryotic systems, under stress conditions”. Recently, there has been a focus on the production and characterization of protein nanocatalysts, nanoantibodies, nanobioreactors, and the production of nanocarriers. Dr. Valdez's work has transcended from the academic to the industrial sphere through her advisory work and collaborations with companies such as Alvartis Pharma, Probiomed, Laboratorios Sophia, Biofabrica Siglo XXI, Dragon Lab, and Grupo LEI. Dr. Valdez participates in projects in collaboration with the Tecnológico de Monterrey, CICATA del Politécnico Nacional, the University of Barcelona, the Pontifical Catholic University of Valparaíso, the University of Chile and Novo Nordisk. She stands out for his teaching work, graduating nine undergraduate students, nine master's students, and three doctorates. It currently trains four postgraduate students. Her group received the Fundación UNAM Award for Pharmaceutical Innovation 2017, the Alfredo Sánchez Marroquin Award in 2021 and 2015, and the Best Undergraduate Thesis Protocol awards from the SMBB in 2015 and 2011 in 2024. She was awarded a scholarship from the “Bill & Melinda Gates Foundation.” Its institutional work encompasses evaluations in the Commissions of the Primary Program for the performance of academic personnel of the Institute of Chemistry and the Faculty of Chemistry at UNAM. As a tutor, she participates in postgraduate programs in evaluation and admission committees. Its line of investigation focuses on developing new biopharmaceuticals, vaccines, and recombinant proteins for diagnostic use, focuses on agriculture characterizing biofertilizers, and on biotechnology applied to water treatment and the treatment of emerging contaminants.
Índice de visibilidad digital v1.0 · Mide qué tan completo está el perfil, no la calidad académica. Escala: 0–39 incompleto · 40–79 intermedio · 80–100 completo. ¿Cómo se calcula? · ¿Te falta un dato? Avísanos
| Nombre | NORMA ADRIANA VALDEZ CRUZ |
|---|---|
| Área | BIOLOGÍA Y QUÍMICA |
| Campo | CIENCIAS DE LA VIDA |
| Disciplina | BIOTECNOLOGÍA |
| Especialidad | BIOLOGIA MOLECULAR DE MICROORGANISMOS |
| CVU | 90992 |
| Institución | |
|---|---|
| Tipo de institución | Pública |
| Dependencia | COORDINACION DE LA INVESTIGACION CIENTIFICA |
| Entidad | BAJA CALIFORNIA |
| Nivel | 2 |
| Vigencia | Inicio: 01/01/2026 |
| Fin: 31/12/2030 |
Evolución en el SNII
- Nivel I: 2007–2021
- Nivel II: 2022–2026
Publicaciones ORCID
- 2026
- Measuring hydrodynamic stress in mammalian cell culture across five decades: Cellular responses and the need for mechanistic integration Biotechnology Advances
- Production of recombinant human granulocyte‐macrophage colony‐stimulating factor in thermoinducible E. coli: Tuning inclusion body architecture and protein yield via dissolved oxygen control Journal of Chemical Technology & Biotechnology
- Nonpolar and Polar Lipids Composition in Recombinant Chinese Hamster Ovary Cells by Nile Red Staining Flow Cytometry European Journal of Lipid Science and Technology
- Mannitol concentration is a determinant of the mycorrhizal infectivity of the Laccaria trichodermophora mycelium produced in liquid culture Fungal Biology
- Catalytically active inclusion bodies of Bacillus clausii laccase protein recombinantly produced in E. coli for dye decolorization Microbial Cell Factories
- Bacterial Extracellular Vesicles (BEVs): Biogenesis, Functions, and Applications
- 2025
- A unified topology-based classification of SARS-CoV-2 RBD neutralizing antibodies systematizes affinity trends across variants mAbs
- Culture conditions shape metabolism and exopolysaccharide production in Piscirickettsia salmonis: implications for vaccine development Aquaculture International
- The flow of proteins through the mammalian secretory pathway described by a phenomenological-based semi-physical model Biochemical Engineering Journal
- 2024
- A comprehensive study of glucose and oxygen gradients in a scaled-down model of recombinant HuGM-CSF production in thermoinduced Escherichia coli fed-batch cultures Preparative Biochemistry & Biotechnology
